Vincent John Corvari,Barbara Ann Williams,Patrick Daniel Donovan,Aaron Paul Markham
申请号：
US15178583
公开号：
US09845353B2
申请日:
2016.06.10
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides stabilized pharmaceutical formulations for anti-IL-17 antibodies, comprising e.g. citrate, sodium chloride and polysorbate-80 at pH 5.7. These stabilized anti-IL-17 antibody pharmaceutical formulations can be used to treat rheumatoid arthritis, psoriasis, ankylosing spondilitis, psoriatic arthritis or multiple myeloma.
